GGGPX
Price
$46.10
Change
+$0.07 (+0.15%)
Updated
Dec 2 closing price
Net Assets
1.51B
VTSAX
Price
$163.82
Change
+$0.69 (+0.42%)
Updated
Dec 3 closing price
Net Assets
2.05T
Interact to see
Advertisement

GGGPX vs VTSAX

Header iconGGGPX vs VTSAX Comparison
Open Charts GGGPX vs VTSAXBanner chart's image
Goldman Sachs Large Cap Equity P
Price$46.10
Change+$0.07 (+0.15%)
VolumeN/A
Net Assets1.51B
Vanguard Total Stock Mkt Idx Adm
Price$163.82
Change+$0.69 (+0.42%)
VolumeN/A
Net Assets2.05T
GGGPX vs VTSAX Comparison Chart in %
View a ticker or compare two or three
VS
GGGPX vs. VTSAX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGGPX is a Buy and VTSAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 2.05T vs. GGGPX (1.51B). VTSAX pays higher dividends than GGGPX: VTSAX (1.11) vs GGGPX (0.43). GGGPX was incepted earlier than VTSAX: GGGPX (8 years) vs VTSAX (25 years). GGGPX (0.76) is less costly to investors than VTSAX (0.04). GGGPX is a more actively managed with annual turnover of: 57.00 vs. VTSAX (2.00). GGGPX has a lower initial minimum investment than VTSAX: GGGPX (0) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 11.45 vs. GGGPX (2.95). VTSAX return over 5 years is better than : 77.21 vs. GGGPX (40.49).
GGGPXVTSAXGGGPX / VTSAX
Total Expense Ratio0.690.041,725%
Annual Report Gross Expense Ratio0.760.041,900%
Fund Existence8 years25 years-
Gain YTD16.23715.513105%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.51B2.05T0%
Annual Yield % from dividends0.431.1139%
Returns for 1 year2.9511.4526%
Returns for 3 years44.4764.4669%
Returns for 5 years40.4977.2152%
Returns for 10 yearsN/A223.73-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMNDF0.02N/A
N/A
BIOMIND LABS INC.
HXPLF8.15N/A
N/A
Hexpol AB
JRONY47.37N/A
N/A
Jeronimo Martins, SGPS, SA
PTCHF1.68N/A
N/A
PureTech Health PLC
IREHF0.21N/A
N/A
Integrated Research Ltd.